Loading…
More significance of TB‐IGRA except for the diagnose of tuberculosis
Objective Tuberculosis (TB)‐interferon gamma release assay (IGRA) test has the characteristics of short time, high specificity, and high sensitivity, but it lacks the correlation research between TB‐IGRA test results and body's immune cells, disease progression and prognosis, which is explored...
Saved in:
Published in: | Journal of clinical laboratory analysis 2018-01, Vol.32 (1), p.n/a |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4483-7ac1ec5e98b4bea664614b254cfe04eb5912afa19c5dad88827ac93a8a8bd0813 |
---|---|
cites | cdi_FETCH-LOGICAL-c4483-7ac1ec5e98b4bea664614b254cfe04eb5912afa19c5dad88827ac93a8a8bd0813 |
container_end_page | n/a |
container_issue | 1 |
container_start_page | |
container_title | Journal of clinical laboratory analysis |
container_volume | 32 |
creator | Xu, Jun‐Chi Li, Ze‐Yi Chen, Xin‐Nian Shi, Cui‐Lin Wu, Mei‐Ying Chen, Hui Zhu, Xiao‐Yan Song, Hua‐Feng Wu, Min‐Juan Xu, Ping |
description | Objective
Tuberculosis (TB)‐interferon gamma release assay (IGRA) test has the characteristics of short time, high specificity, and high sensitivity, but it lacks the correlation research between TB‐IGRA test results and body's immune cells, disease progression and prognosis, which is explored in this study.
Design
A retrospective study was carried out on positive TB‐IGRA patients who were infected with TB and diagnosed at our hospital from January 2014 to June 2015. The TB‐IGRA, routine blood test, T‐cell subgroup data were collected for statistical analysis.
Results
TB‐IGRA results were in positive proportion to the lymphocytes, CD4+T cells and CD4+CD28+T cells, whereas negative to the Treg cells. Patient with unilateral pulmonary lesion had higher TB‐IGRA than those with bilateral pulmonary lesions. After the stimulation of TB‐specific antigen, the proportion of CD4+IFN‐γ+ and CD8+IFN‐γ+T Tcells were both increased and the CD4+IFN‐γ+T had positive correlation with the value of TB‐IGRA.
Conclusions
IFN‐γ was tested with TB‐IGRA in patients with TB by the specific TB T cells and correlated with the lymphocytes, while the lymphocytes also closely related to the host's anti‐TB immunity and disease outcome. Hence the result of TB‐IGRA could reflect the specific anti‐TB immunity ability of the host, disease progression and prognosis. This study further expands the application scope of TB‐IGRA technology in the diagnosis of TB and lays a foundation for clinical practice to understand the immunity state of the patients with TB and the application of auxiliary clinical immunity regulators. |
doi_str_mv | 10.1002/jcla.22183 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6817251</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1870645028</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4483-7ac1ec5e98b4bea664614b254cfe04eb5912afa19c5dad88827ac93a8a8bd0813</originalsourceid><addsrcrecordid>eNp9kU1rFEEQhhtRzBq9-ANkwIsIk1T1fFVfhM1iPmRFkHhuenpqNr3MTq_dM2pu_gR_o78ks9kYogdPdXifeqjiFeIlwhECyOO17cyRlEjZIzFDUJRKksVjMQOiKiXA7EA8i3ENAKSwfCoOplyCqtRMnH70gZPoVr1rnTW95cS3yeXJ75-_Ls4-zxP-YXk7JK0PyXDFSePMqvfxFhrGmoMdOx9dfC6etKaL_OJuHoovp-8vF-fp8tPZxWK-TG2eU5ZWxiLbghXVec2mLPMS81oWuW0Zcq4LhdK0BpUtGtMQkZw2VGbIUN0AYXYo3u2927HecGO5H4Lp9Da4jQnX2hun_056d6VX_psuCStZ7ARv7gTBfx05DnrjouWuMz37MWqkCsq8AEkT-vofdO3H0E_vaVSkihIA5US93VM2-BgDt_fHIOhdPXpXj76tZ4JfPTz_Hv3TxwTgHvjuOr7-j0p_WCzne-kN2iibWw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1989560012</pqid></control><display><type>article</type><title>More significance of TB‐IGRA except for the diagnose of tuberculosis</title><source>NCBI_PubMed Central(免费)</source><creator>Xu, Jun‐Chi ; Li, Ze‐Yi ; Chen, Xin‐Nian ; Shi, Cui‐Lin ; Wu, Mei‐Ying ; Chen, Hui ; Zhu, Xiao‐Yan ; Song, Hua‐Feng ; Wu, Min‐Juan ; Xu, Ping</creator><creatorcontrib>Xu, Jun‐Chi ; Li, Ze‐Yi ; Chen, Xin‐Nian ; Shi, Cui‐Lin ; Wu, Mei‐Ying ; Chen, Hui ; Zhu, Xiao‐Yan ; Song, Hua‐Feng ; Wu, Min‐Juan ; Xu, Ping</creatorcontrib><description>Objective
Tuberculosis (TB)‐interferon gamma release assay (IGRA) test has the characteristics of short time, high specificity, and high sensitivity, but it lacks the correlation research between TB‐IGRA test results and body's immune cells, disease progression and prognosis, which is explored in this study.
Design
A retrospective study was carried out on positive TB‐IGRA patients who were infected with TB and diagnosed at our hospital from January 2014 to June 2015. The TB‐IGRA, routine blood test, T‐cell subgroup data were collected for statistical analysis.
Results
TB‐IGRA results were in positive proportion to the lymphocytes, CD4+T cells and CD4+CD28+T cells, whereas negative to the Treg cells. Patient with unilateral pulmonary lesion had higher TB‐IGRA than those with bilateral pulmonary lesions. After the stimulation of TB‐specific antigen, the proportion of CD4+IFN‐γ+ and CD8+IFN‐γ+T Tcells were both increased and the CD4+IFN‐γ+T had positive correlation with the value of TB‐IGRA.
Conclusions
IFN‐γ was tested with TB‐IGRA in patients with TB by the specific TB T cells and correlated with the lymphocytes, while the lymphocytes also closely related to the host's anti‐TB immunity and disease outcome. Hence the result of TB‐IGRA could reflect the specific anti‐TB immunity ability of the host, disease progression and prognosis. This study further expands the application scope of TB‐IGRA technology in the diagnosis of TB and lays a foundation for clinical practice to understand the immunity state of the patients with TB and the application of auxiliary clinical immunity regulators.</description><identifier>ISSN: 0887-8013</identifier><identifier>ISSN: 1098-2825</identifier><identifier>EISSN: 1098-2825</identifier><identifier>DOI: 10.1002/jcla.22183</identifier><identifier>PMID: 28220979</identifier><language>eng</language><publisher>United States: John Wiley & Sons, Inc</publisher><subject>Adult ; CD28 antigen ; CD4 antigen ; CD4-Positive T-Lymphocytes - immunology ; CD8 antigen ; Female ; Humans ; Immunoassay ; Interferon ; Interferon-gamma - analysis ; Interferon-gamma - immunology ; Interferon-gamma - metabolism ; Interferon-gamma Release Tests - statistics & numerical data ; Leukocytes, Mononuclear - immunology ; Lungs ; Lymphocytes ; Lymphocytes T ; Male ; Medical diagnosis ; Middle Aged ; Mycobacterium tuberculosis ; Prognosis ; Pulmonary lesions ; Retrospective Studies ; TB‐IGRA ; Tuberculosis ; Tuberculosis - diagnosis ; Tuberculosis - epidemiology ; Tuberculosis - immunology ; γ‐interferon</subject><ispartof>Journal of clinical laboratory analysis, 2018-01, Vol.32 (1), p.n/a</ispartof><rights>2017 Wiley Periodicals, Inc.</rights><rights>Copyright © 2018 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4483-7ac1ec5e98b4bea664614b254cfe04eb5912afa19c5dad88827ac93a8a8bd0813</citedby><cites>FETCH-LOGICAL-c4483-7ac1ec5e98b4bea664614b254cfe04eb5912afa19c5dad88827ac93a8a8bd0813</cites><orcidid>0000-0002-1447-7593</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817251/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817251/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28220979$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xu, Jun‐Chi</creatorcontrib><creatorcontrib>Li, Ze‐Yi</creatorcontrib><creatorcontrib>Chen, Xin‐Nian</creatorcontrib><creatorcontrib>Shi, Cui‐Lin</creatorcontrib><creatorcontrib>Wu, Mei‐Ying</creatorcontrib><creatorcontrib>Chen, Hui</creatorcontrib><creatorcontrib>Zhu, Xiao‐Yan</creatorcontrib><creatorcontrib>Song, Hua‐Feng</creatorcontrib><creatorcontrib>Wu, Min‐Juan</creatorcontrib><creatorcontrib>Xu, Ping</creatorcontrib><title>More significance of TB‐IGRA except for the diagnose of tuberculosis</title><title>Journal of clinical laboratory analysis</title><addtitle>J Clin Lab Anal</addtitle><description>Objective
Tuberculosis (TB)‐interferon gamma release assay (IGRA) test has the characteristics of short time, high specificity, and high sensitivity, but it lacks the correlation research between TB‐IGRA test results and body's immune cells, disease progression and prognosis, which is explored in this study.
Design
A retrospective study was carried out on positive TB‐IGRA patients who were infected with TB and diagnosed at our hospital from January 2014 to June 2015. The TB‐IGRA, routine blood test, T‐cell subgroup data were collected for statistical analysis.
Results
TB‐IGRA results were in positive proportion to the lymphocytes, CD4+T cells and CD4+CD28+T cells, whereas negative to the Treg cells. Patient with unilateral pulmonary lesion had higher TB‐IGRA than those with bilateral pulmonary lesions. After the stimulation of TB‐specific antigen, the proportion of CD4+IFN‐γ+ and CD8+IFN‐γ+T Tcells were both increased and the CD4+IFN‐γ+T had positive correlation with the value of TB‐IGRA.
Conclusions
IFN‐γ was tested with TB‐IGRA in patients with TB by the specific TB T cells and correlated with the lymphocytes, while the lymphocytes also closely related to the host's anti‐TB immunity and disease outcome. Hence the result of TB‐IGRA could reflect the specific anti‐TB immunity ability of the host, disease progression and prognosis. This study further expands the application scope of TB‐IGRA technology in the diagnosis of TB and lays a foundation for clinical practice to understand the immunity state of the patients with TB and the application of auxiliary clinical immunity regulators.</description><subject>Adult</subject><subject>CD28 antigen</subject><subject>CD4 antigen</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD8 antigen</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoassay</subject><subject>Interferon</subject><subject>Interferon-gamma - analysis</subject><subject>Interferon-gamma - immunology</subject><subject>Interferon-gamma - metabolism</subject><subject>Interferon-gamma Release Tests - statistics & numerical data</subject><subject>Leukocytes, Mononuclear - immunology</subject><subject>Lungs</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Male</subject><subject>Medical diagnosis</subject><subject>Middle Aged</subject><subject>Mycobacterium tuberculosis</subject><subject>Prognosis</subject><subject>Pulmonary lesions</subject><subject>Retrospective Studies</subject><subject>TB‐IGRA</subject><subject>Tuberculosis</subject><subject>Tuberculosis - diagnosis</subject><subject>Tuberculosis - epidemiology</subject><subject>Tuberculosis - immunology</subject><subject>γ‐interferon</subject><issn>0887-8013</issn><issn>1098-2825</issn><issn>1098-2825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kU1rFEEQhhtRzBq9-ANkwIsIk1T1fFVfhM1iPmRFkHhuenpqNr3MTq_dM2pu_gR_o78ks9kYogdPdXifeqjiFeIlwhECyOO17cyRlEjZIzFDUJRKksVjMQOiKiXA7EA8i3ENAKSwfCoOplyCqtRMnH70gZPoVr1rnTW95cS3yeXJ75-_Ls4-zxP-YXk7JK0PyXDFSePMqvfxFhrGmoMdOx9dfC6etKaL_OJuHoovp-8vF-fp8tPZxWK-TG2eU5ZWxiLbghXVec2mLPMS81oWuW0Zcq4LhdK0BpUtGtMQkZw2VGbIUN0AYXYo3u2927HecGO5H4Lp9Da4jQnX2hun_056d6VX_psuCStZ7ARv7gTBfx05DnrjouWuMz37MWqkCsq8AEkT-vofdO3H0E_vaVSkihIA5US93VM2-BgDt_fHIOhdPXpXj76tZ4JfPTz_Hv3TxwTgHvjuOr7-j0p_WCzne-kN2iibWw</recordid><startdate>201801</startdate><enddate>201801</enddate><creator>Xu, Jun‐Chi</creator><creator>Li, Ze‐Yi</creator><creator>Chen, Xin‐Nian</creator><creator>Shi, Cui‐Lin</creator><creator>Wu, Mei‐Ying</creator><creator>Chen, Hui</creator><creator>Zhu, Xiao‐Yan</creator><creator>Song, Hua‐Feng</creator><creator>Wu, Min‐Juan</creator><creator>Xu, Ping</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1447-7593</orcidid></search><sort><creationdate>201801</creationdate><title>More significance of TB‐IGRA except for the diagnose of tuberculosis</title><author>Xu, Jun‐Chi ; Li, Ze‐Yi ; Chen, Xin‐Nian ; Shi, Cui‐Lin ; Wu, Mei‐Ying ; Chen, Hui ; Zhu, Xiao‐Yan ; Song, Hua‐Feng ; Wu, Min‐Juan ; Xu, Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4483-7ac1ec5e98b4bea664614b254cfe04eb5912afa19c5dad88827ac93a8a8bd0813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>CD28 antigen</topic><topic>CD4 antigen</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD8 antigen</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoassay</topic><topic>Interferon</topic><topic>Interferon-gamma - analysis</topic><topic>Interferon-gamma - immunology</topic><topic>Interferon-gamma - metabolism</topic><topic>Interferon-gamma Release Tests - statistics & numerical data</topic><topic>Leukocytes, Mononuclear - immunology</topic><topic>Lungs</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Male</topic><topic>Medical diagnosis</topic><topic>Middle Aged</topic><topic>Mycobacterium tuberculosis</topic><topic>Prognosis</topic><topic>Pulmonary lesions</topic><topic>Retrospective Studies</topic><topic>TB‐IGRA</topic><topic>Tuberculosis</topic><topic>Tuberculosis - diagnosis</topic><topic>Tuberculosis - epidemiology</topic><topic>Tuberculosis - immunology</topic><topic>γ‐interferon</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xu, Jun‐Chi</creatorcontrib><creatorcontrib>Li, Ze‐Yi</creatorcontrib><creatorcontrib>Chen, Xin‐Nian</creatorcontrib><creatorcontrib>Shi, Cui‐Lin</creatorcontrib><creatorcontrib>Wu, Mei‐Ying</creatorcontrib><creatorcontrib>Chen, Hui</creatorcontrib><creatorcontrib>Zhu, Xiao‐Yan</creatorcontrib><creatorcontrib>Song, Hua‐Feng</creatorcontrib><creatorcontrib>Wu, Min‐Juan</creatorcontrib><creatorcontrib>Xu, Ping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical laboratory analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, Jun‐Chi</au><au>Li, Ze‐Yi</au><au>Chen, Xin‐Nian</au><au>Shi, Cui‐Lin</au><au>Wu, Mei‐Ying</au><au>Chen, Hui</au><au>Zhu, Xiao‐Yan</au><au>Song, Hua‐Feng</au><au>Wu, Min‐Juan</au><au>Xu, Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>More significance of TB‐IGRA except for the diagnose of tuberculosis</atitle><jtitle>Journal of clinical laboratory analysis</jtitle><addtitle>J Clin Lab Anal</addtitle><date>2018-01</date><risdate>2018</risdate><volume>32</volume><issue>1</issue><epage>n/a</epage><issn>0887-8013</issn><issn>1098-2825</issn><eissn>1098-2825</eissn><abstract>Objective
Tuberculosis (TB)‐interferon gamma release assay (IGRA) test has the characteristics of short time, high specificity, and high sensitivity, but it lacks the correlation research between TB‐IGRA test results and body's immune cells, disease progression and prognosis, which is explored in this study.
Design
A retrospective study was carried out on positive TB‐IGRA patients who were infected with TB and diagnosed at our hospital from January 2014 to June 2015. The TB‐IGRA, routine blood test, T‐cell subgroup data were collected for statistical analysis.
Results
TB‐IGRA results were in positive proportion to the lymphocytes, CD4+T cells and CD4+CD28+T cells, whereas negative to the Treg cells. Patient with unilateral pulmonary lesion had higher TB‐IGRA than those with bilateral pulmonary lesions. After the stimulation of TB‐specific antigen, the proportion of CD4+IFN‐γ+ and CD8+IFN‐γ+T Tcells were both increased and the CD4+IFN‐γ+T had positive correlation with the value of TB‐IGRA.
Conclusions
IFN‐γ was tested with TB‐IGRA in patients with TB by the specific TB T cells and correlated with the lymphocytes, while the lymphocytes also closely related to the host's anti‐TB immunity and disease outcome. Hence the result of TB‐IGRA could reflect the specific anti‐TB immunity ability of the host, disease progression and prognosis. This study further expands the application scope of TB‐IGRA technology in the diagnosis of TB and lays a foundation for clinical practice to understand the immunity state of the patients with TB and the application of auxiliary clinical immunity regulators.</abstract><cop>United States</cop><pub>John Wiley & Sons, Inc</pub><pmid>28220979</pmid><doi>10.1002/jcla.22183</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-1447-7593</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0887-8013 |
ispartof | Journal of clinical laboratory analysis, 2018-01, Vol.32 (1), p.n/a |
issn | 0887-8013 1098-2825 1098-2825 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6817251 |
source | NCBI_PubMed Central(免费) |
subjects | Adult CD28 antigen CD4 antigen CD4-Positive T-Lymphocytes - immunology CD8 antigen Female Humans Immunoassay Interferon Interferon-gamma - analysis Interferon-gamma - immunology Interferon-gamma - metabolism Interferon-gamma Release Tests - statistics & numerical data Leukocytes, Mononuclear - immunology Lungs Lymphocytes Lymphocytes T Male Medical diagnosis Middle Aged Mycobacterium tuberculosis Prognosis Pulmonary lesions Retrospective Studies TB‐IGRA Tuberculosis Tuberculosis - diagnosis Tuberculosis - epidemiology Tuberculosis - immunology γ‐interferon |
title | More significance of TB‐IGRA except for the diagnose of tuberculosis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T05%3A49%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=More%20significance%20of%20TB%E2%80%90IGRA%20except%20for%20the%20diagnose%20of%20tuberculosis&rft.jtitle=Journal%20of%20clinical%20laboratory%20analysis&rft.au=Xu,%20Jun%E2%80%90Chi&rft.date=2018-01&rft.volume=32&rft.issue=1&rft.epage=n/a&rft.issn=0887-8013&rft.eissn=1098-2825&rft_id=info:doi/10.1002/jcla.22183&rft_dat=%3Cproquest_pubme%3E1870645028%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4483-7ac1ec5e98b4bea664614b254cfe04eb5912afa19c5dad88827ac93a8a8bd0813%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1989560012&rft_id=info:pmid/28220979&rfr_iscdi=true |